Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8073123 | 0.85 | KMT2A (0.40) | RAB9ATSHRKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL8218234 | 0.72 | HPGD (0.30) | SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL17823015 | 0.70 | HDAC8 (0.37) | RAB9ATSHRKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL7768024 | 0.69 | HDAC3 (0.33) | HDAC8HDAC6 | |
| SCHEMBL6438616 | 0.69 | — | — | |
| SCHEMBL8168259 | 0.68 | HDAC8 (0.38) | RAB9ATSHRKMT2AMEN1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL2117827 | 0.68 | HDAC8 (0.35) | RAB9ATSHRKMT2AMEN1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL2116438 | 0.68 | HDAC8 (0.35) | RAB9ATSHRKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL727844 | 0.67 | HDAC8 (0.37) | RAB9ATSHRKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL7935890 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7169863-B2 | Salts of lewis acid/acid adducts and catalyst activators therefrom | DOW GLOBAL TECHNOLOGIES INC. (US) | 2007-01-30 | — | — | US | disclosed |
| US-7094901-B2 | Expanded anionic compounds comprising hydroxyl or quiescent reactive functionality and catalyst activators therefrom | DOW GLOBAL MICHIGAN TECHNOLOGIES INC. (US) | 2006-08-22 | — | — | US | disclosed |
| EP-1228109-B1 | SUPPORTED CATALYST COMPRISING EXPANDED ANIONS | DOW GLOBAL TECHNOLOGIES INC (US) | 2006-02-01 | — | — | EP | disclosed |
| US-20050009688-A1 | Expanded anionic compounds comprising hydroxyl or quiescent reactive functionality and catalyst activators therefrom | BABB DAVID A (US) | 2005-01-13 | — | — | US | disclosed |
| US-20040162215-A1 | Salts of lewis acid/acid adducts and catalyst activators therefrom | THE DOW CHEMICAL COMPANY | 2004-08-19 | — | — | US | disclosed |
| EP-1412365-A1 | SALT OF LEWIS ACID/ACID ADDUCTS AND CATALYST ACTIVATORS THEREFROM | DOW GLOBAL TECHNOLOGIES INC. (US) | 2004-04-28 | — | — | EP | disclosed |
| US-20040077491-A1 | Expanded anionic compounds comprising hydroxyl or quiescent reactive functionality and catalyst activators therefrom | THE DOW CHEMICAL COMPANY (US) | 2004-04-22 | — | — | US | disclosed |
| US-6716786-B1 | LEWIS ACIDS AND BASES | THE DOW CHEMICAL COMPANY | 2004-04-06 | — | — | US | disclosed |
| US-6627573-B2 | Useful as a cocatalyst for addition coordination polymerization comprising an anion containing at least two Lewis basic sites which are coordinated to Lewis acids, and further containing a hydroxyl group for support attachment | THE DOW CHEMICAL COMPANY | 2003-09-30 | — | — | US | disclosed |
| EP-1056752-B1 | Catalyst activators comprising expanded anions | DOW GLOBAL TECHNOLOGIES INC (US) | 2003-06-25 | — | — | EP | disclosed |
| US-20030032549-A1 | Salts of lewis acid/acid adducts and catalyst activators therefrom | DOW GLOBAL TECHNOLOGIES INC. | 2003-02-13 | — | — | US | disclosed |
| WO-2003010171-A1 | SALT OF LEWIS ACID/ACID ADDUCTS AND CATALYST ACTIVATORS THEREFROM | DOW GLOBAL TECHNOLOGIES, INC. (US) | 2003-02-06 | — | — | WO | disclosed |
| US-6462156-B2 | AS POLYMERIZATION CATALYST FOR PRODUCING OLEFIN POLYMERS | THE DOW CHEMICAL COMPANY | 2002-10-08 | — | — | US | disclosed |
| US-20020032120-A1 | Expanded anionic compounds comprising hydroxyl or quiescent reactive functionality and catalyst activators therefrom | DOW CHEMICAL COMPANY, THE | 2002-03-14 | — | — | US | disclosed |
| US-20010027161-A1 | Catalyst activators comprising expanded anions | THE DOW CHEMICAL COMPANY | 2001-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030032549-A1 | Salts of lewis acid/acid adducts and catalyst activators therefrom | SSB, NCF1, CD79B | RAB9A 1152/4885TSHR 2471/4885KMT2A 2251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.